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 Autoimmune hepatitis (AIH) is frequently associated with 
extrahepatic autoimmune disorders such as rheumatoid ar-
thritis, Sjogren's syndrome, and chronic thyroiditis, but the 
association with idiopathic (immune) thrombocytopenic 
purpura (ITP) is rare. We report a 46-year-old Japanese 
woman who presented with severe thrombocytopenia, ele-
vated levels of aminotransferases, immunoglobulin (Ig) G, 
and platelet-associated IgG (PAIgG), positive anti-nuclear 
antibody, and hypothyroidism. After a diagnosis of coexist-
ing AIH, ITP, and chronic thyroiditis, the patient was 
treated with 30 mg/day of prednisolone orally. The patient 
responded to such treatment: showing an increase in the 
number of platelets and decrease of serum levels of 
aminotransferases, IgG, and PAIgG to within normal 
ranges. Discrimination of ITP from liver cirrhosis as a 
cause of severe thrombocytopenia seen in chronic liver dis-
ease is important because complications and therapy are 
quite different. Prednisolone as a treatment for All should 
be also effective for ITP, and therefore, ITP should be con-
sidered when liver dysfunction is accompanied by severe 
thrombocytopenia, particularly in the autoimmune types of 
liver diseases. 
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Introduction
 Autoimmune hepatitis (AIH) is a chronic necroinflamma-
tory liver disorder that occurs predominantly in 
women and is characterized by the presence of circu-
lating autoantibodies and hypergammaglobulinemia." 
Affected individuals often have concurrent extrahepatic 
autoimmune disorders such as rheumatoid arthritis, 
Sjogren's syndrome (SjS), and chronic thyroiditis, 2' but 
association with idiopathic (immune) thrombocytopenic 
purpura (ITP) has been rarely reported in Japan." 
                                                                                          - 9'
 In the present report, we describe a patient of AIH 
associated with ITP and chronic thyroiditis who was 
successfully treated with prednisolone.
Case Report
 A 46-year-old Japanese woman was referred to 
Nagasaki University Hospital, Japan, in March 1998 for 
investigation of elevated levels of serum aminotransferases 
and thrombocytopenia. Fourteen months previously 
she was found to have elevated levels of aminotransferases 
with aspartate aminotransferase (AST) level of 97 IU/1 
and alanine aminotransferaese (ALT) level of 147 IU/1 
associated with 2-month history of anorexia and gen-
eral malaise. She was not a smoker, and reported an 
average alcohol intake of <25 g/day for 8 years. The 
family history was negative for liver diseases and the 
patient denied exposure to agents relevant to hepatitis 
including blood transfusion or drugs. Physical exami-
nation on admission showed no hepatosplenomegaly, 
jaundice, or mucocutaneous bleeding. 
 Laboratory data on admission (Tables 1 and 2) 
showed severe thrombocytopenia, and elevated levels 
of erythrocyte sedimentation rate, total bilirubin, 
hepato-biliary enzymes, and gamma-globulin. Serum 
levels of immunoglobulin (Ig) G and IgM were
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Table 1. Laboratory data on admission (1)
Test Results Normal range 
Peripheral blood 
     White blood cells (/g.') 2,700 (3,600 - 8,500) 
     Red blood cells (x10"/µ') 427 (390-500)
     Hemoglobin (g/dl) 13.1 (11.0 -14.5) 
     Platelets (x104/p.') 3.2 (15-38) 
     Prothrombin time (%a) 95 (82-127) 
     Activated partial thromboplastin time (second) 30.6 (25.2 - 34.4) 
     Fibrinogen (mg/dl) 229 (168-329)
     Erythrocyte sedimentation rate (mm/hr) 60 (10-20) 
Blood chemistry 
     Total bilirubin (mg/dl) 1.8 (0.2-1.0) 
     Direct bilirubin (mg/dl) 1.0 (0-0.5) 
     Total protein (g/dl) 8.7 (6.2-8.0) 
        Albumin (g/dl) 3.6 (3.8-4.9) 
        Gamma-globulin (g/dl) 3.18 (0.7-1.5) 
     Aspartate aminotransferase (IU/1) 462 (11-39) 
     Alanine aminotransferase (IU/1) 520 (4-33) 
     Lactate dehydrogenase (IU/1) 427 (202-435) 
    Alkaline phosphatase (IU/1) 443 (88-270) 
     Leucine aminopeptidase (IU/I) 161 (40-100) 
     Gamma-glutamyl transpeptidase (IU/1) 180 (0-50) 
     Cholinesterase (ApH/hr) 0.89 (0.6-1.3) 
     Thymol turbidity test (U) 32.5 (0-4) 
     Zinc turbidity test (U) 41.8 (4-12) 
     Total cholesterol (mg/dl) 179 (111-247) 
Tumor markers 
     Alpha-fetoprotein (ng/ml) 80 (<10) 
     Des-gamma-carboxy prothrombin (mAU/ml) 48 (<40)
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Figure 1. Clinical course. Administration of prednisolone re-
duced serum alanine aminotransferase (ALT), anti-nuclear an-
tibody (ANA), immunoglobulin (Ig) G, and platelet-associated 
IgG (PAIgG), and also increased platelet (PLT) count.
Table 2. Laboratory data on admission (2)
Test Results Normal range 
Immunology 
     Immunoglobulin G (mg/dl) 3,879 (972 - 2,010) 
    Immunoglobulin M (mg/dl) 461 (67-359)
    Immunoglobulin A (mg/dl) 447 (90-445) 
    CH50 (U/ml) 36.2 (20-60) 
    C3 (mg/dl) 57 (42-107) 
    C4 (mg/dl) 11.7 (14-40) 
     Anti-nuclear antibody x2,560 (diffuse pattern) 
    Anti-dsDNA antibody (IU/ml) 198 (<12) 
    Anti-ssDNA antibody (AU/ml) 197 (<25) 
     Anti-mitochondrial antibody (-) (<x20) 
     Anti-smooth muscle antibody x640 (<x40) 
     Rheumatoid factor (lU/ml) 27 (<14) 
     Anti-Ro/SS-A antibody (ID) 60.9 (gray zone: 7 - 20) 
     Anti-La/SS-B antibody (ID) 3.2 (gray zone: 10 - 25) 
     Anti-platelet antibody (-) 
     Platelet-associated immunoglobulin G (ng/107 cells) 274.2 (9-25) 
Thyroid function tests 
     Free T3 (pg/ml) 2.1 (2.7-4.5) 
     Free T4 (ng/dl) 0.8 (1.0-1.8) 
     Thyroid stimulating hormone (µU/ml) 6.26 (0.3-3.2) 
     Thyroid test x1,600 
     Microsome test x400 
Hepatitis virus markers 
     IgM antibody to hepatitis A virus (-) 
     Hepatitis B surface antigen (HBsAg) (-)
    Antibody to HBsAg (anti-HBs) (-) 
     Hepatitis B e antigen (HBeAg) (-)
    Antibody to HBeAg (anti-HBe) (-) 
     Antibody to hepatitis B core antigen (anti-HBc) (-)
    Antibody to hepatitis C virus (anti-HCV) (COI*) 0.4 (<1.0) 
*Cut-off index (second-generation enzyme-linked immunosorbent assay) .
elevated. Rheumatoid factor, anti-nuclear antibody 
(ANA), antibodies against single-stranded DNA and 
double-stranded DNA, anti-smooth muscle antibody, 
and anti-Ro/SS-A antibody were positive, but anti-
mitochondrial antibody was negative. Anti-platelet an-
tibody was negative, but platelet-associated IgG 
(PAIgG) was positive. Thyroid function tests revealed 
hypothyroidism with positive results of thyroid test 
(anti-thyroglobulin particle agglutination) and microsome 
test (anti-thyroid microsomal particle agglutination). 
All tests for serum markers of hepatitis A, B, or C 
virus infections were negative. Abdominal computed 
tomography (CT) showed mild splenomegaly but no 
hepatobiliary mass or stones. Thyroid ultrasonography
Figure 2. Histopathological examination of the liver biopsy 
specimen obtained in June 1998 showing fibrous portal ex-
pansion with predominantly lymphoplasmacytic infiltrates 
but no interface hepatitis. (H-E stain, x100)
revealed no thyroid swelling or mass. Bone marrow 
aspirate showed normoplastic marrow with an in-
crease in the number of megakaryocytes. Schirmer's 
test was negative. According to the revised scoring 
system for the diagnosis of AIH,t°< an aggregate score 
was 17 before treatment, indicative of "definite AIH" 
based on the following individual scores: female gen-
der (+2); ALP:AST ratio <1.5 (+2); serum IgG 1.5-2.0 
times above normal (+2); ANA titer 1:2560 (+3); 
seronegative for hepatitis viral markers (+3); no drug 
history (+1); average alcohol intake <25 g/day (+2); 
other autoimmune disease ITP (+2). 
 The diagnosis of AIH, ITP, and chronic thyroiditis 
was made based on the aforementioned clinical and 
laboratory findings. Because of the severe 
thrombocytopenia, liver biopsy was not performed at 
that stage. The patient was treated with 30 mg/day
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of prednisolone, and thereafter the number of platelets 
increased and the serum levels of aminotransferases, 
IgG, and PAIgG returned to within normal limits 
(Figure 1). Examination of a percutaneous liver biopsy 
specimen obtained in June 1998 showed fibrous por-
tal expansion with predominantly lymphoplasmacytic 
infiltrates but no interface hepatitis (Figure 2). The 
dose of prednisolone was tapered and was maintained 
at 7.5 mg/day. She remains well and results of liver 
function tests at the latest follow-up in June 2001 
were within normal range. The aggregate AIH score 
increased to 20 after treatment and liver biopsy (pre-
dominantly lymphoplasmacytic infiltrates on liver his-
tology; +1, complete response to therapy; +2), again in-
dicative of "definite AIH".l0'
Discussion
 A specific feature of AIH is the association of 
extrahepatic immune-mediated syndromes." According 
to a nationwide survey in Japan," extrahepatic 
autoimmune disorders were present in 229 (28%) of 
817 patients with AIH, and the most frequent disor-
ders were rheumatoid arthritis (10%), SjS (10%), and 
chronic thyroiditis (10%). However, the association of 
ITP in patient with AIH has been rarely reported in 
Japan, and the prevalence is around 2%.4.12' 
 The etiopathological association between AIH and 
ITP is obscure at present. ITP is an autoimmune dis-
ease characterized by a low platelet count, 
mucocutaneous bleeding, normal bone marrow findings, 
and the absence of other causes of thrombocytopenia in 
which anti-platelet autoantibodies such as PAIgG in-
duces platelet destruction.",") Pfueller et al. reported 
that of 24 patients with AIH, 13 (54%) had low plate-
let counts and 17 (71%) had elevated levels of PAIgG.15' 
The same group also reported that 12 (92%) of 13 AIH 
patients with thrombocytopenia had elevated levels of 
PAIgG, and overall, PAIgG levels in AIH correlated 
with the degree of thrombocytopenia and increased 
levels of serum IgG.15' The clinical course of our pa-
tient was in line with this finding because serum lev-
els of PAIgG and IgG decreased simultaneously after 
prednisolone treatment. 
 Another possible mechanism is an AIH-SjS-ITP asso-
ciation. As described above, AIH frequently associates 
with SjS, and the prevalence of complicating 
thrombocytopenia in patients with SjS has been re-
ported to be approximately 15%.1617 However, our pa-
tient did not suffer from SjS because of the lack of 
xerostomia and keratoconjunctivitis, and the negative 
result of Schirmer's test. Systemic lupus erythematosus
(SLE)-associated hepatitis should also be considered in 
our patient because thrombocytopenia caused by pe-
ripheral immune destruction is relatively common in 
SLE (20-40%).18' However, the diagnostic criteria of 
SLE were not fulfilled in our patient,") and the inter-
national AIH score indicated our patient as "definite 
AIH". 
 Thrombocytopenia frequently occurs in chronic liver 
diseases, and may often be considered a predictive 
sign of evolution to liver cirrhosis. This is thought to 
be due to the sequestrating function of an enlarged 
spleen (hypersplenism), the presence of anti-platelet 
antibodies, and/or impaired production of thrombopoietin 
in cirrhotic patients.",") Discrimination of ITP from 
liver cirrhosis as a cause of severe thrombocytopenia 
is important because complications and therapy are 
quite different. In most cases of ITP, marked 
splenomegaly is seldom seen and the liver function 
tests such as serum albumin, cholinesterase, and 
prothrombin time are not so impaired. Indeed, 
prednisolone administered as a treatment for AIH was 
also effective for ITP in our patient. Therefore, ITP 
should be considered when liver dysfunction is accom-
panied by severe thrombocytopenia, particularly in 
the autoimmune types of liver diseases."'
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